Both in Biotechnology
Adaptive Biotechnologies vs Tarsus Pharmaceuticals
Over the past year ADPT returned +48.8% and TARS returned +4.1%; their daily moves had a correlation of 0.17.
ADPT +48.8% TARS +4.1%Growth of $1, one year, split-adjusted
| Metric | ADPT | TARS |
|---|---|---|
| Price | $25.80 | $72.64 |
| Market cap | $4.12B | $3.40B |
| Today | +2.95% | −0.93% |
| 1 month | −13.5% | −2.4% |
| 6 months | +87.2% | +11.7% |
| Year to date | +58.9% | −11.3% |
| 1 year | +48.6% | +5.6% |
| Revenue growth (YoY) | +21.5% | +69.4% |
| Gross margin | 71.8% | 93.0% |
| Net margin | −55.6% | −10.7% |
| P/E (TTM) | — | — |
| Price / sales | 13.4× | 5.6× |
| Net cash | $9.4M | $376.9M |
| Dividend yield | — | — |
| Volatility (60d) | 51.1% | 46.1% |
| Short % of float | 10.0% | 15.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).